review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1248/BPB.28.1590 |
P8608 | Fatcat ID | release_vuxshfn545fz7d2gthaxwowkqu |
P698 | PubMed publication ID | 16141521 |
P5875 | ResearchGate publication ID | 7618932 |
P2093 | author name string | Yasuji Matsuoka | |
Takahiko Shimizu | |||
Takuji Shirasawa | |||
P433 | issue | 9 | |
P304 | page(s) | 1590-1596 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Biological and Pharmaceutical Bulletin | Q15754240 |
P1476 | title | Biological significance of isoaspartate and its repair system | |
P478 | volume | 28 |
Q46320596 | APP/Aβ structural diversity and Alzheimer's disease pathogenesis |
Q35044254 | Accelerated protein damage in brains of PIMT+/- mice; a possible model for the variability of cognitive decline in human aging |
Q46984100 | Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome |
Q37124928 | Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease |
Q36984283 | An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins |
Q41970463 | Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry |
Q41962414 | Antifragility and Tinkering in Biology (and in Business) Flexibility Provides an Efficient Epigenetic Way to Manage Risk |
Q38717942 | Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
Q39041113 | Assessment of disulfide and hinge modifications in monoclonal antibodies |
Q57146442 | Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions |
Q48388591 | Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis |
Q99616740 | Ceruloplasmin oxidized and deamidated by Parkinson's disease cerebrospinal fluid induces epithelial cells proliferation arrest and apoptosis |
Q36084372 | Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy. |
Q53622461 | Co-occurrence of both L-asparaginase subtypes in Arabidopsis: At3g16150 encodes a K+-dependent L-asparaginase. |
Q34384948 | Considerations in the identification of endogenous substrates for protein L-isoaspartyl methyltransferase: the case of synuclein |
Q37729814 | Cross-regulation between protein L-isoaspartyl O-methyltransferase and ERK in epithelial mesenchymal transition of MDA-MB-231 cells |
Q41814945 | Deamidation accelerates amyloid formation and alters amylin fiber structure |
Q36596625 | Dementia-linked amyloidosis is associated with brain protein deamidation as revealed by proteomic profiling of human brain tissues |
Q41833694 | Detection and quantitation of succinimide in intact protein via hydrazine trapping and chemical derivatization |
Q35742895 | Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation |
Q38281208 | Differentiating N-terminal aspartic and isoaspartic acid residues in peptides. |
Q30986578 | Differentiation and Semiquantitative Analysis of an Isoaspartic Acid in Human α-Crystallin by Postsource Decay in a Curved Field Reflectron |
Q85001526 | Differentiation of α- or β-aspartic isomers in the heptapeptides by the fragments of [M + Na]+ using ion trap tandem mass spectrometry |
Q47147272 | Distinguishing Aspartic and Isoaspartic Acids in Peptides by Several Mass Spectrometric Fragmentation Methods |
Q99570536 | Diversity and Regulation of S-Adenosylmethionine Dependent Methyltransferases in the Anhydrobiotic Midge |
Q34629775 | Fibronectin: functional character and role in alcoholic liver disease |
Q52652714 | Gas Phase Ion Chemistry to Determine Isoaspartate in a Peptide Backbone. |
Q45966440 | Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond. |
Q47941813 | Identification of Novel Site-Specific Alterations in the Modification Level of Myelin Basic Protein Isolated from Mouse Brain at Different Ages Using Capillary Electrophoresis-Mass Spectrometry. |
Q42076718 | Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions |
Q38210860 | Impaired proteostasis: role in the pathogenesis of diabetes mellitus |
Q42225476 | In-Source Decay Characterization of Isoaspartate and β-Peptides |
Q30426046 | Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice |
Q57721642 | Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer's Disease |
Q35041665 | Isoaspartate accumulation in mouse brain is associated with altered patterns of protein phosphorylation and acetylation, some of which are highly sex-dependent |
Q30319326 | Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases |
Q33793594 | Isoaspartyl formation in creatine kinase B is associated with loss of enzymatic activity; implications for the linkage of isoaspartate accumulation and neurological dysfunction in the PIMT knockout mouse |
Q37637164 | Isoaspartyl protein damage and repair in mouse retina |
Q58347215 | Isomerization and epimerization of the aspartyl tetrapeptide Ala-Phe-Asp-GlyOH at pH 10-A CE study |
Q37728867 | Knock-down of protein L-isoaspartyl O-methyltransferase increases β-amyloid production by decreasing ADAM10 and ADAM17 levels |
Q37080680 | Lessons from two prevalent amyloidoses-what amylin and Aβ have in common |
Q44517032 | Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF. |
Q34586965 | Modification of the L1-CAM carboxy-terminus in pancreatic adenocarcinoma cells |
Q34695506 | Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms. |
Q37043304 | N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits |
Q37086218 | N52 monodeamidated Bcl‑xL shows impaired oncogenic properties in vivo and in vitro |
Q43107956 | Natural selection and immortality |
Q38790836 | Negative ion cleavages of (M-H)(-) anions of peptides. Part 3. Post-translational modifications |
Q58023432 | Observation of heterogeneous gene products by FT-ICR MS |
Q37563576 | Oxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling |
Q50996852 | Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis. |
Q28540168 | Post-translational modifications modulate ligand recognition by the third PDZ domain of the MAGUK protein PSD-95 |
Q94956418 | Profiling the 'deamidome' of complex biosamples using mixed-mode chromatography-coupled tandem mass spectrometry |
Q34110227 | Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process |
Q82617246 | Protein repair L-isoaspartyl methyltransferase 1 is involved in both seed longevity and germination vigor in Arabidopsis |
Q46753891 | Protein repair in the brain, proteomic analysis of endogenous substrates for protein L-isoaspartyl methyltransferase in mouse brain |
Q28569469 | Protein-L-isoaspartate (D-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst1 |
Q33254719 | Proteomic identification of novel substrates of a protein isoaspartyl methyltransferase repair enzyme |
Q46849768 | Purification of monomeric prolactin charge isoform from buffalo pituitaries |
Q35604177 | Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease |
Q47133483 | Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease |
Q41048721 | Repair of isoaspartate formation modulates the interaction of deamidated 4E-BP2 with mTORC1 in brain |
Q27679248 | Role of N-Terminal Myristylation in the Structure and Regulation of cAMP-Dependent Protein Kinase |
Q36939985 | Role of transmethylation reactions in alcoholic liver disease |
Q37973942 | Scaling up synthetic biology: Do not forget the chassis |
Q45969140 | Sequence and Solution Effects on the Prevalence of d-Isomers Produced by Deamidation. |
Q28478926 | Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures |
Q93089168 | Spontaneous Isomerization of Long-Lived Proteins Provides a Molecular Mechanism for the Lysosomal Failure Observed in Alzheimer's Disease |
Q28539968 | Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions |
Q36862637 | Synthetic biology: discovering new worlds and new words |
Q37420318 | The V119I polymorphism in protein L-isoaspartate O-methyltransferase alters the substrate-binding interface |
Q30009421 | The impact of extra-domain structures and post-translational modifications in the folding/misfolding behaviour of the third PDZ domain of MAGUK neuronal protein PSD-95. |
Q51503969 | The protective role of protein L-isoaspartyl (D-aspartate) O-methyltransferase for maintenance of mitochondrial morphology in A549 cell. |
Q33621850 | The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease |
Q43821424 | Theoretical study on isomerization and peptide bond cleavage at aspartic residue. |
Q37373293 | Toward proteome-scale identification and quantification of isoaspartyl residues in biological samples. |
Search more.